+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Orthoclone OKT3 Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6103915
The orthoclone OKT3 market research report is one of a series of new reports that provides orthoclone OKT3 market statistics, including the orthoclone OKT3 industry global market size, regional shares, competitors with the orthoclone OKT3 market share, detailed orthoclone OKT3 market segments, market trends, and opportunities, and any further data you may need to thrive in the orthoclone OKT3 industry. This orthoclone OKT3 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to the shift to personalized medicine, the adoption of combination therapies, rising access to healthcare, favorable reimbursement policies, and growing investment in biopharmaceutical research. Major trends in the forecast period include the development of monoclonal antibody technologies, technological innovations in biomanufacturing, advances in genetic engineering, telemedicine integration, and the integration of AI in treatment plans.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the orthoclone OKT3 market. Chronic diseases, which include conditions such as diabetes, heart disease, and asthma, are long-lasting and often require ongoing management and care. Their rising incidence is linked to aging populations, unhealthy lifestyles such as poor diets and physical inactivity, and heightened prevalence of risk factors such as obesity, diabetes, and hypertension. Orthoclone OKT3, a monoclonal antibody targeting the CD3 receptor on T-cells, plays a crucial role in managing chronic diseases by modulating immune responses, reducing inflammation, and preventing immune-mediated damage in conditions such as organ transplant rejection and autoimmune disorders. For example, in June 2024, data from the Australian Institute of Health and Welfare highlighted an increase in age-standardized death rates associated with chronic conditions, from 459 per 100,000 in 2021 to 490 per 100,000 in 2022. This trend underscores the growing demand for treatments such as orthoclone OKT3.

The rising number of organ transplants is another factor propelling the growth of the orthoclone OKT3 market. Organ transplants, which involve transferring a donor organ to a recipient, have been increasing globally due to medical advancements, a higher prevalence of chronic diseases causing organ failure, greater awareness of organ donation, and improvements in surgical techniques and donor registries. Orthoclone OKT3 is instrumental in organ transplants by suppressing acute rejection episodes through inhibition of T-cell-mediated immune responses, thereby enhancing graft survival and patient outcomes. For instance, reports from the United Network for Organ Sharing (UNOS) in January 2023 indicated that 42,887 organ transplants were performed in the United States in 2022, a 3.7% increase compared to 2021. This growing trend in organ transplants supports the expansion of the orthoclone OKT3 market.

The rising healthcare expenditure is expected to contribute significantly to the growth of the orthoclone OKT3 market. Increased financial allocation toward health services, driven by factors such as aging populations, chronic diseases, medical advancements, and heightened demand for healthcare, bolsters the development and accessibility of treatments such as Orthoclone OKT3. This medication helps reduce overall healthcare costs by improving transplant success rates and minimizing the need for retransplantation. For example, a report published in May 2023 by the UK Office for National Statistics revealed a 5.6% increase in healthcare spending between 2022 and 2023, compared to a 0.9% growth in 2022, with total expenditure reaching approximately $317.63 billion (£292 billion) in 2023. Such increased investment in healthcare infrastructure and services further supports the market for orthoclone OKT3.

The key company operating in the orthoclone okt3 market is Centocor Ortho Biotech Products LP

North America was the largest region in the orthoclone OKT3 market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in orthoclone OKT3 report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the orthoclone OKT3 market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Orthoclone OKT3, also known as muromonab-CD3, is a monoclonal antibody medication that targets the CD3 receptor on T cells. It is primarily used to manage acute rejection episodes in organ transplant patients by suppressing the immune system and protecting transplanted organs from immune-mediated destruction.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary indications for orthoclone OKT3 include transplant rejection and autoimmune diseases. Transplant rejection occurs when the immune system identifies a transplanted organ or tissue as foreign and attacks it, which can result in transplant failure. The medication is distributed through various channels, including direct sales, distributors, and online pharmacies, and is utilized by end users such as hospitals, specialty clinics, and research institutions.

The orthoclone okt3 market consists of sales of basiliximab, daclizumab, alemtuzumab, and anti-thymocyte globulin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Orthoclone OKT3 Market Characteristics
3. Orthoclone OKT3 Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Orthoclone OKT3 Market Trends And Strategies5. Orthoclone OKT3 Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
6. Global Orthoclone OKT3 Growth Analysis And Strategic Analysis Framework
6.1. Global Orthoclone OKT3 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Orthoclone OKT3 Market Growth Rate Analysis
6.4. Global Orthoclone OKT3 Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Orthoclone OKT3 Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Orthoclone OKT3 Total Addressable Market (TAM)
7. Global Orthoclone OKT3 Pricing Analysis & Forecasts
8. Orthoclone OKT3 Market Segmentation
8.1. Global Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Transplant Rejection
  • Autoimmune Diseases
8.2. Global Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Direct Sales
  • Distributors
  • Online Pharmacies
8.3. Global Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospitals
  • Specialty Clinics
  • Research Institutions
9. Global Orthoclone OKT3 Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Orthoclone OKT3 Market Regional And Country Analysis
10.1. Global Orthoclone OKT3 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Orthoclone OKT3 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Orthoclone OKT3 Market
11.1. Asia-Pacific Orthoclone OKT3 Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Orthoclone OKT3 Market
12.1. China Orthoclone OKT3 Market Overview
12.2. China Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Orthoclone OKT3 Market
13.1. India Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Orthoclone OKT3 Market
14.1. Japan Orthoclone OKT3 Market Overview
14.2. Japan Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Orthoclone OKT3 Market
15.1. Australia Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Orthoclone OKT3 Market
16.1. South Korea Orthoclone OKT3 Market Overview
16.2. South Korea Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Orthoclone OKT3 Market
17.1. Western Europe Orthoclone OKT3 Market Overview
17.2. Western Europe Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Orthoclone OKT3 Market
18.1. UK Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Orthoclone OKT3 Market
19.1. Germany Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Orthoclone OKT3 Market
20.1. France Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Orthoclone OKT3 Market
21.1. Eastern Europe Orthoclone OKT3 Market Overview
21.2. Eastern Europe Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Orthoclone OKT3 Market
22.1. North America Orthoclone OKT3 Market Overview
22.2. North America Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Orthoclone OKT3 Market
23.1. USA Orthoclone OKT3 Market Overview
23.2. USA Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Orthoclone OKT3 Market
24.1. Canada Orthoclone OKT3 Market Overview
24.2. Canada Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Orthoclone OKT3 Market
25.1. South America Orthoclone OKT3 Market Overview
25.2. South America Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Orthoclone OKT3 Market
26.1. Middle East Orthoclone OKT3 Market Overview
26.2. Middle East Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Orthoclone OKT3 Market
27.1. Africa Orthoclone OKT3 Market Overview
27.2. Africa Orthoclone OKT3 Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Orthoclone OKT3 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Orthoclone OKT3 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Orthoclone OKT3 Market Competitive Landscape And Company Profiles
28.1. Orthoclone OKT3 Market Competitive Landscape
28.2. Orthoclone OKT3 Market Company Profiles
28.2.1. Centocor Ortho Biotech Products LP Overview, Products and Services, Strategy and Financial Analysis
29. Global Orthoclone OKT3 Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Orthoclone OKT3 Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Orthoclone OKT3 Market32. Recent Developments In The Orthoclone OKT3 Market
33. Orthoclone OKT3 Market High Potential Countries, Segments and Strategies
33.1 Orthoclone OKT3 Market In 2029 - Countries Offering Most New Opportunities
33.2 Orthoclone OKT3 Market In 2029 - Segments Offering Most New Opportunities
33.3 Orthoclone OKT3 Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright And Disclaimer

Executive Summary

Orthoclone OKT3 Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orthoclone okt3 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for orthoclone okt3 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orthoclone okt3 market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Indication: Transplant Rejection; Autoimmune Diseases
2) By Distribution Channel: Direct Sales; Distributors; Online Pharmacies
3) By End User: Hospitals; Specialty Clinics; Research Institutions

Key Companies Profiled: Centocor Ortho Biotech Products LP

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Centocor Ortho Biotech Products LP